Henry Schein Inc: (NASD: HSIC)
$96.59
-1.56 (-1.59%)
Volume 246,614
Jun 19 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 96.51 - 98.18 |
| 52wk Low - High | 72.84 - 98.28 |
| Previous Close | 98.15 |
| Avg. Volume | 372,776 |
| Industry | MED/DENTAL-SUPP |
| Market Cap | 8.55 B |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.78 |
| P/E (F1) | 20.20 |
| Current Year Est. | 4.86 |
| Quarterly Earnings ESP |
-1.64% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
165 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| P/E (F1) | 20.20 |
| PEG Ratio | 1.92 |
| Current Year Est. | 4.86 |
| Current Quarter Estimate | 1.22 |
| Most Accurate Estimate | 1.20 |
| Earnings ESP |
-1.64% |
| Next Earnings Report Date | 08-08-2013 |
| EPS Last Year | 4.51 |
| Expected Earnings Growth | 10.50% |
Company Description
Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The company conducts its business principally through two segments; healthcare distribution and technology. These segments, which are operated as individual business units, offer different products and services, albeit to the same customer base. The healthcare distribution segment consists of the company's dental, medical, veterinary and international groups.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 1.22 | 1.20 | 4.86 | 5.38 |
| Number of Estimates | 11 | 11 | 13 | 13 |
| Low Estimate | 1.16 | 1.17 | 4.81 | 5.15 |
| High Estimate | 1.26 | 1.27 | 4.88 | NA |
| Year Ago EPS | 1.11 | 1.08 | 4.44 | 4.86 |
| EPS Growth | 9.58% | 11.53% | 9.44% | 10.81% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| HENRY SCHEIN IN | HSIC | 98.15 | |
|
| LUXOTTICA ADR | LUX | 53.64 | |
|
| STAAR SURGICAL | STAA | 10.51 | |
|
| ALIGN TECH INC | ALGN | 36.25 | |
|
| BECTON DICKINSO | BDX | 100.40 | |
|
| CONMED CORP | CNMD | 32.03 | |
|
| COOPER COS | COO | 121.69 | |
|
| STERIS CORP | STE | 44.78 | |
|
| WEST PHARM SVC | WST | 68.17 | |
|
| BARD C R INC | BCR | 111.80 | |
|
Sector:Medical>> Industry:MED/DENTAL-SUPP
COMPARE TICKER vs. Its Peers
Zacks Commentary
Henry Schein and Masimo Ink New Deal
Jun 13, 2013
Will Patterson Miss Earnings this Quarter?
May 22, 2013
HSIC Misses Earnings Despite Y/Y Gain
May 08, 2013
Will CVS Earnings Miss this Quarter?
Apr 30, 2013
Becton Receives 510(k) Clearance
Apr 15, 2013
HWAY and SulAmerica in Agreement
Apr 15, 2013
Reiterate DENTSPLY at Neutral
Apr 03, 2013
Abaxis Pinned at Neutral
Apr 01, 2013
Financials
| EPS TTM | 4.51 |
| Sales | 8,940 |
| Net Income | 399 |
| Price/Earnings | 21.76 |
| Price/Book | 3.33 |
| Price/Cash Flow | 16.48 |
| Price/Sales | 0.94 |
News
Finding Strength in Healthcare Supplies - TheMotleyFool
Jun 17, 2013
Benzinga`s Top Initiations - Benzinga
Jun 13, 2013
Masimo Signs Far-Reaching Pulse Oximetry Distribution Deal with Butler Schein Animal Health - Benzinga
Jun 11, 2013
Align Technology, Henry Schein Releases Realine Product Line for Non-Invisalign GP Dentists - Benzinga
Jun 3, 2013
This Health Care Stock Looks Good - TheMotleyFool
Jun 3, 2013
Henry Schein Beats on Revenue, Matches Expectations on EPS - TheMotleyFool
May 7, 2013
UPDATE: Henry Schein Q1 Profit Rises 13% - Benzinga
May 7, 2013
What to Expect from Henry Schein - TheMotleyFool
May 6, 2013
Broker Recommendations
| Current ABR | 2.29 |
| ABR (Last Week) | 2.29 |
| # of recs in ABR | 14 |
| Average Target Price | 90.72 |
| Industry Rank by ABR | 165 out of 265 |
| Rank in Industry | 9 out of 29 |
